Investing.com -- Kura Oncology (NASDAQ:KURA) shares rose 9% Friday following the release of preliminary trial data showing its drug combination demonstrated activity in patients with clear cell renal ...

Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI therapy 44% ORR and 94% DCR in ccRCC patients previously treat ...

Houston, TX-based oilfield services provider Baker Hughes is set to acquire Chart Industries’ in a $13.6 billion that significantly expands the former’s presence in the liquid natural gas market. The ...

Twenty-seven years ago today, a Broadway legend who also wrote a long list of hit songs died of cancer in Florida.

Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare ...

The systemic lupus erythematosus (SLE) market continues to evolve toward biologic-driven care, with increasing treatment complexity, intensifying competition among advanced therapies, and a robust ...

VB4-P5 - novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney disease • CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) -- XORTX Therape ...

Unicycive Therapeutics Inc. advanced stock charts by Barron's. View UNCY historical stock data and compare to other stocks, and exchanges.

External Affairs Minister S. Jaishankar's visit to Mauritius has delivered a series of impactful outcomes across health, ...

AI model using head CT imaging predicts in-hospital mortality for patients with gunshot wounds to the head with high discriminative performance.

Mineralys Therapeutics recently appointed Jeffrey A. Munsie as Chief Legal Officer, adding nearly 25 years of biopharma legal experience as the company advances lorundrostat for cardiorenal conditions ...

SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...